



Edi<;ao da Sociedade Portuguesa de Ciencias Farmaceuticas 
1.0 Encontro Nacional de Quimica Terapeutica 
1st National Meeting on Medicinal Chemistry 
13-15 N ovembro ' 08 
PORTO, PORTUGAL 
LIVRO DE RESUMOS 
BOOK OF ABSTRACTS 
OIPORTO 
g~,CA ~ FACULDADE DE FARMACIA ORGAIIICA 
..::=. ~"'POOE UN IVERSIDADE DO PORTO 
D( QUIMicA ~=llCA 
ISS::\T 0484 - 811 X 
\ lolume LII (n .0 3) 
Suplemento 
P-059 
INCORPORATION OF 2-STYRYLCHROMONES IN LIPOSOMES: PRELIMINARIES 
STUDIES 
M. Carlos8 *, D. Almeida8 , A. Gomesb, E. Fernandesb, J. L. F. C. Limab, A. M. S. Silvac, D. C. G. A. 
Pinto\ C. M. M. SantosC, J. A. S. Cavaleiroc, R. Gas para, M. L. Corvoa,d 
aiMed. UL, 2i-Med. UL Research Institute for Medicines and Pharmaceutical Sciences, Faculdade de 
Farmacia, Universidade de Lisboa, Portugal 
6 REQUIMTE., Departamento de Quimica-Fisica, Faculdade de Farmacia, Universidade do Porto, 
Portugal 
cDepartamento de Quimica, Universidade de Aveiro, 3810-193 Aveiro, Portugal 
dUNFAB-INETI Lisboa, Portugal 
§ miscarlos@ff. ul.pt 
Abstract 
Several compounds with a 2-styrylchromone chemical structure have been shown to hold a high 
antioxidant activity in vitro, at low concentrations, which indicates a potential therapeutic value 
that needs to be confirmed in vivo [1-2] . The evaluation of the antioxidant potential of 2-
styrylcromones, in vivo, is expected to beneficiate from a formulation that delivers the compound 
to specific target sites. Due to the structural analogies of 2-styrylcromones with flavonoids, a 
controlled delivery system - liposomes - vvas chosen to take advantage of the well known 
pharmacokinetic behaviour of liposome-incorporated flavonoids. Liposomes are lamellar lipidic 
structures which form almost spontaneously when certain lipids are hydrated in aqueous media 
[3 ,4]. 
This work presents, for the first rime, the results of the incorporation of 2-styrylcromones in 
liposomes. The characterization of the obtained formulations was based in the study of the 
encapsulation efficiency of L~e compound in liposomes, the knowledgment of the primary 
concentration of compound in Ll:e incorporation process and the effect of the addition of freeze-
drying protector, threalose. :o ±e ::ormulation. 
The obtained results shO\\'e~ :1-.z: :-s:yrylcromones could be encapsulated in lipossomes with 
high incorporation efficienc~ . ~e illghest encapsulation efficiency was achieved with a 
concentration of drug of : ... E o· :---e.: i _J ;rmol of total lipid. The results concerning the addition of 
threalose to the fornuia:io= inril- :!:ed that the use of the freeze-drying protector reduces the 
effects caused by freeze-d.:-:-::.;. ~-::-.as the growth of the vesicles. 
This liposomal formula:i~:: ~ =-·~ :eci !O allow the diffusion of these compounds to the target 
site in therapeutic conce:: --_ - ~ 
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